The information on this website is exactly that, for information purposes only. This information is not intended to be a substitute for sound medical advice or for seeing a physician. Patients should always consult with their physician before starting any medical treatment. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Understanding Virus, especially COVID19 types:
It is a surprise to most of us that a virus is not a living organism. Unlike bacteria that are alive, the virus does not biologically meet the criteria of a living organism; having a cell, generating energy, has within itself molecules to sustain itself and does not reproduce.
Although not considered by biologists as alive, the virus can replicate or make a copy of itself, not a new being as in reproduction. You might consider it a carbon copy. Why is that distinction so important? The virus needs a living host to survive, at least a moist environment.
For instance, the COVID19 virus resides in moisture, i.e. small droplets on hard surfaces, in the air and within humans or other animals. They travel the nasopharynx to the target organ, the moist lungs.
Vaccines are the present-day best means of defense by causing the body to increase specific cellular immunity to the specific virus. However, the following should be noted.
“Antiviral drugs do not destroy their target pathogen, but instead they inhibit its progression into the living cell. Designing safe and effective antiviral drugs is difficult because viruses use the host’s cells to replicate. This makes it difficult to find targets for the drug that would interfere with the virus without also harming the host organism’s cells. Moreover, the major difficulty in developing vaccines and anti-viral drugs is due to viral variation.” (https://en.wikipedia.org/wiki/Antiviral_drug)
A new anti-viral drug has been discovered that solves the difficulties mentioned in the paragraph above.
This patented drug is called protocatechuic acid or PCA for short and has been issued an US patent # 10,959,969 on March 30, 2021; Methods of treating SARS Cov-2 virus with protocatechuic acid.
What is so Special about PCA?
PCA’s mode of action is unique. The target is the virus itself. This is feasible due to the unique physical shape of PCA’s sharp spear-like protrusions. These protrusions that break through the thin coating on the SARS V-2 virus exposing the proteins within, thereby inactivating the virus. Note the word inactivate is used and not killing as the virus is not a living organism.
What about Mutations are more infectious?
PCA’s destruction of the virus itself is critical therapeutically going forward as mutations have and will occur; Delta mutation. No further biological puzzle needs to be solved with the mutations as they all possess the same thin lipoid (fatty) coating that should be easily disrupted and destroys the virus no matter what mutation.
PCA Does More
PCA does not stop there with its attach on the virus. PCA has an acid pH which further destroys the virus. In addition, similar to other indirect therapies, PCA has an anti-protease and blocking function that follows.
The additional anti-thrombosis property of PCA will be evaluated in planned clinical trials. The cellular and hormonal immunity observed in reports in the literature on animals will be tested as well.